Membrane anchoring of epstein-barr virus gp42 inhibits fusion with B cells even with increased flexibility allowed by engineered spacers

Keyphrases

• Amino 4%
• Amino Acids 4%
• B Cell Receptor 4%
• B Cells 100%
• Burkitt Lymphoma 4%
• C-type Lectin Domain 4%
• Cell Fusion 14%
• Class Function 4%
• Dominant Negative Effect 4%
• Encoded Protein 4%
• Epithelial Cells 4%
• Epstein-Barr Virus 100%
• Functional Form 4%
• Fusion Activity 4%
• Fusion Function 9%
• Gastric Carcinoma 4%
• Glycoprotein 4%
• Gp42 100%
• Hodgkin Lymphoma 4%
• Human Leukocyte Antigen Class II 9%
• Immune Dysfunction 4%
• Immune Suppression 4%
• Immunoglobulin Domain 9%
• Linker 9%
• Lymphoproliferative Disorders 4%
• Membrane Anchor 100%
• Membrane Binding 23%
• Membrane Glycoproteins 4%
• Membrane Orientation 4%
• Membrane-bound Form 9%
• Mononucleosis 4%
• Muscle Protein 4%
• Nasopharyngeal Carcinoma 4%
• Steric Hindrance 9%
• Titin 9%
• Transmembrane Domain 4%
• Unstructured Regions 4%
• Viral Fusion 4%
• Virus B 4%
• Virus Tropism 4%

Immunology and Microbiology

• Amino Terminal Sequence 28%
• B Cell 100%
• B-Cell Receptor 14%
• C-Type Lectin 14%
• Cell Fusion 42%
• Epstein Barr Virus 100%
• Glycoprotein 28%
• Human Leukocyte Antigen 28%
• Immune System Disorders 14%
• Immunity 14%
• Immunoglobulin Domain 28%
• Lymphoproliferative Disorders 14%
• Mononucleosis 14%
• Stereospecificity 28%
• Viral Tropism 14%

Pharmacology, Toxicology and Pharmaceutical Science

• Amino Acid 14%
• B Lymphocyte Receptor 14%
• Burkitt's Lymphoma 14%
• Connectin 28%
• Disease 14%
• Epstein-Barr Virus 100%
• Glycoprotein 14%
• Hodgkin Disease 14%
• Immunoglobulin 28%
• Lectin 14%
• Leukocyte Antigen 28%
• Lymphoproliferative Disease 14%
• Membrane Protein 14%
• Mononucleosis 14%
• Muscle Protein 14%
• Nasopharynx Carcinoma 14%
• Stomach Carcinoma 14%